Index RUT
P/E 10.38
EPS (ttm) 1.37
Insider Own 3.05%
Shs Outstand 23.60M
Perf Week 2.24%
Market Cap 339.65M
Forward P/E 16.84
EPS next Y 0.84
Insider Trans -1.07%
Shs Float 23.24M
Perf Month 11.57%
Income 32.59M
PEG 2.08
EPS next Q 0.17
Inst Own 99.98%
Short Float 6.55%
Perf Quarter 24.63%
Sales 281.54M
P/S 1.21
EPS this Y -52.65%
Inst Trans -1.73%
Short Ratio 7.30
Perf Half Y -14.23%
Book/sh 8.37
P/B 1.69
EPS next Y 39.54%
ROA 11.80%
Short Interest 1.52M
Perf Year 3.66%
Cash/sh 3.07
P/C 4.61
EPS next 5Y 5.00%
ROE 18.13%
52W Range 9.69 - 16.95
Perf YTD -0.91%
Dividend Est. -
P/FCF 9.95
EPS past 5Y 29.16%
ROI 13.44%
52W High -16.40%
Beta 1.18
Dividend TTM -
Quick Ratio 3.89
Sales past 5Y 14.31%
Gross Margin 71.17%
52W Low 46.16%
ATR (14) 0.46
Dividend Ex-Date -
Current Ratio 4.44
EPS Y/Y TTM 5999.12%
Oper. Margin 6.74%
RSI (14) 61.92
Volatility 3.10% 3.26%
Employees 992
Debt/Eq 0.24
Sales Y/Y TTM 5.71%
Profit Margin 11.58%
Recom 1.00
Target Price 20.33
Option/Short Yes / Yes
LT Debt/Eq 0.21
EPS Q/Q 4248.84%
Payout 0.00%
Rel Volume 2.17
Prev Close 14.24
Sales Surprise 0.36%
EPS Surprise 37.62%
Sales Q/Q 7.14%
Earnings Aug 05 AMC
Avg Volume 208.41K
Price 14.17
SMA20 5.74%
SMA50 9.21%
SMA200 2.64%
Trades
Volume 451,647
Change -0.49%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-13-20 Upgrade
Oppenheimer
Perform → Outperform
$55
Oct-22-19 Initiated
Oppenheimer
Perform
Aug-07-19 Upgrade
BTIG Research
Neutral → Buy
$62
Jun-13-19 Initiated
Dougherty & Company
Buy
$80
Jan-02-19 Upgrade
Northland Capital
Under Perform → Market Perform
Jun-04-18 Downgrade
Northland Capital
Market Perform → Under Perform
Feb-27-18 Downgrade
Northland Capital
Outperform → Market Perform
Dec-08-17 Initiated
Sidoti
Neutral
Nov-09-17 Upgrade
BTIG Research
Neutral → Buy
Oct-12-17 Initiated
Guggenheim
Buy
$47
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Loading…
09:30AM
Aug-06-24 01:59PM
(Thomson Reuters StreetEvents) +13.86%
Aug-05-24 06:15PM
05:11PM
(Associated Press Finance)
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
May-07-24 10:48AM
07:04AM
Loading…
07:04AM
(Thomson Reuters StreetEvents)
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
(Associated Press Finance)
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
04:05PM
Loading…
Apr-15-24 04:05PM
Apr-12-24 05:45PM
01:53PM
Apr-03-24 12:00PM
Apr-01-24 09:40AM
Mar-14-24 09:40AM
Mar-13-24 09:55AM
Feb-27-24 09:40AM
Feb-26-24 09:55AM
Feb-23-24 09:55AM
Feb-21-24 09:26AM
Feb-20-24 10:39PM
(Thomson Reuters StreetEvents)
06:34PM
08:40AM
08:11AM
07:38AM
(Associated Press Finance)
07:30AM
Feb-05-24 04:05PM
Feb-01-24 06:51PM
Jan-29-24 07:30AM
Nov-08-23 07:30AM
Nov-07-23 10:38AM
10:08AM
(Thomson Reuters StreetEvents)
Nov-06-23 05:44PM
05:03PM
(Associated Press Finance)
04:05PM
Nov-03-23 08:46AM
Oct-03-23 07:30AM
Oct-02-23 04:05AM
Sep-25-23 08:38AM
Sep-19-23 09:00AM
Sep-07-23 07:30AM
Aug-31-23 04:05PM
Aug-10-23 05:41AM
Aug-07-23 06:05PM
04:58PM
04:05PM
Jul-28-23 09:25PM
Jul-21-23 12:19PM
Jul-18-23 08:00AM
Jul-07-23 12:10PM
Jun-29-23 04:05PM
Jun-09-23 11:48AM
May-26-23 11:18AM
May-23-23 07:30AM
May-10-23 06:10AM
May-09-23 10:52AM
10:42AM
(Thomson Reuters StreetEvents)
May-08-23 05:55PM
04:53PM
04:05PM
May-03-23 09:57AM
Mar-30-23 04:05PM
Mar-20-23 02:00PM
Mar-14-23 09:00AM
Mar-02-23 04:05PM
Feb-23-23 09:25PM
04:01PM
Feb-22-23 05:50AM
(Simply Wall St.) +10.73%
Feb-21-23 11:22PM
(Thomson Reuters StreetEvents) -7.56%
08:25AM
07:07AM
06:59AM
Feb-01-23 07:30AM
Jan-22-23 08:06AM
Jan-05-23 07:30AM
Jan-03-23 08:42AM
Dec-28-22 08:50AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ferstler Sherri Lee Senior VP, Sales Aug 12 '24 Sale 13.07 1,550 20,263 38,764 Aug 14 04:26 PM Ferstler Sherri Lee Officer Aug 12 '24 Proposed Sale 13.07 1,550 20,262 Aug 12 05:04 PM Birkemeyer Elaine M. Chief Financial Officer May 16 '24 Sale 13.68 3,041 41,590 61,295 May 20 04:36 PM BURKE WILLIAM W Director May 08 '24 Sale 14.06 2,500 35,150 25,273 May 10 04:24 PM Burns Kristie Sr. VP Mktg & Clinical Affairs May 06 '24 Sale 14.37 815 11,713 62,574 May 08 05:23 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 27 '24 Sale 15.58 1,091 17,001 63,632 Feb 29 08:43 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 29 '24 Sale 15.25 243 3,706 63,389 Feb 29 08:43 PM REUVERS DANIEL L. President and CEO Feb 27 '24 Sale 15.60 4,689 73,148 239,423 Feb 29 08:42 PM REUVERS DANIEL L. President and CEO Feb 29 '24 Sale 15.25 1,396 21,289 238,027 Feb 29 08:42 PM REUVERS DANIEL L. President and CEO Feb 26 '24 Sale 15.81 6,239 98,645 244,112 Feb 27 09:13 PM REUVERS DANIEL L. President and CEO Feb 23 '24 Sale 14.85 5,378 79,853 192,321 Feb 27 09:13 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 23 '24 Sale 14.80 2,249 33,278 53,765 Feb 27 09:12 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 26 '24 Sale 15.90 2,015 32,049 63,512 Feb 27 09:12 PM
Index RUT
P/E 21.89
EPS (ttm) 3.44
Insider Own 2.18%
Shs Outstand 37.68M
Perf Week 3.35%
Market Cap 2.84B
Forward P/E 11.58
EPS next Y 6.50
Insider Trans -28.41%
Shs Float 36.87M
Perf Month 2.62%
Income 136.78M
PEG 1.46
EPS next Q 1.13
Inst Own 102.70%
Short Float 3.61%
Perf Quarter 14.68%
Sales 1.58B
P/S 1.79
EPS this Y 14.70%
Inst Trans -2.71%
Short Ratio 2.66
Perf Half Y 50.84%
Book/sh 36.33
P/B 2.07
EPS next Y 13.11%
ROA 4.96%
Short Interest 1.33M
Perf Year 74.55%
Cash/sh 6.22
P/C 12.11
EPS next 5Y 15.00%
ROE 9.74%
52W Range 41.89 - 80.18
Perf YTD 27.74%
Dividend Est. -
P/FCF 11.50
EPS past 5Y 9.35%
ROI 6.26%
52W High -6.09%
Beta 0.95
Dividend TTM -
Quick Ratio 0.86
Sales past 5Y 11.31%
Gross Margin 57.02%
52W Low 79.76%
ATR (14) 1.90
Dividend Ex-Date Nov 30, 2016
Current Ratio 0.86
EPS Y/Y TTM 60.86%
Oper. Margin 17.18%
RSI (14) 59.28
Volatility 1.89% 2.37%
Employees 9938
Debt/Eq 0.62
Sales Y/Y TTM 9.17%
Profit Margin 8.63%
Recom 1.33
Target Price 87.00
Option/Short Yes / Yes
LT Debt/Eq 0.60
EPS Q/Q 154.00%
Payout 0.00%
Rel Volume 2.66
Prev Close 74.99
Sales Surprise 2.83%
EPS Surprise 6.91%
Sales Q/Q 12.41%
Earnings Aug 06 AMC
Avg Volume 500.61K
Price 75.30
SMA20 2.64%
SMA50 1.33%
SMA200 23.34%
Trades
Volume 1,330,891
Change 0.41%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-27-23 Upgrade
Robert W. Baird
Neutral → Outperform
$47 → $55
Jul-07-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$44
Aug-23-21 Resumed
BMO Capital Markets
Market Perform
$40
Sep-12-19 Initiated
Sidoti
Buy
Sep-13-24 07:00PM
Sep-11-24 03:43AM
Sep-10-24 08:00AM
Sep-09-24 09:40AM
Sep-05-24 07:01PM
11:31AM
Loading…
11:31AM
08:00AM
Sep-03-24 07:01PM
Aug-30-24 01:49AM
Aug-22-24 09:40AM
Aug-20-24 08:00AM
Aug-09-24 11:39PM
Aug-07-24 11:47AM
06:14AM
Aug-06-24 06:50PM
05:58PM
Loading…
05:58PM
(Associated Press Finance)
05:06PM
04:15PM
Aug-05-24 03:10AM
Jul-26-24 03:58AM
Jul-25-24 11:58AM
Jul-18-24 04:49AM
Jul-17-24 02:20PM
Jul-15-24 04:32AM
Jul-11-24 08:30AM
Jul-10-24 08:50AM
Jul-08-24 12:26PM
Jul-02-24 03:55AM
Jun-27-24 05:10AM
Jun-26-24 04:15PM
(Investor's Business Daily)
08:50AM
Loading…
Jun-24-24 08:50AM
Jun-21-24 09:40AM
Jun-20-24 08:20AM
Jun-07-24 11:42AM
Jun-05-24 09:40AM
08:50AM
May-30-24 09:40AM
May-28-24 09:36AM
May-23-24 09:40AM
May-21-24 02:00PM
May-20-24 09:40AM
08:50AM
May-13-24 08:30AM
May-07-24 09:40AM
03:04AM
May-03-24 12:29PM
11:21AM
07:17AM
(Thomson Reuters StreetEvents)
04:10AM
May-02-24 09:55PM
05:43PM
04:57PM
(Associated Press Finance)
04:48PM
04:15PM
May-01-24 03:12AM
Apr-22-24 08:30AM
02:34AM
Apr-17-24 03:40AM
Mar-25-24 08:30AM
Mar-21-24 12:38PM
07:07AM
Mar-13-24 08:00AM
Mar-11-24 06:39AM
Mar-01-24 10:18AM
Feb-29-24 11:30AM
Feb-28-24 10:21AM
Feb-22-24 09:35AM
08:00AM
Feb-13-24 08:00AM
Feb-08-24 09:00PM
10:59AM
Feb-06-24 01:00PM
Feb-02-24 09:40AM
09:35AM
Feb-01-24 01:52PM
Jan-31-24 02:35PM
12:41PM
07:04AM
(Thomson Reuters StreetEvents)
06:42AM
Jan-30-24 06:45PM
05:54PM
05:40PM
(Associated Press Finance)
05:31PM
12:20PM
09:50AM
Jan-19-24 07:57PM
08:00AM
Jan-09-24 09:00AM
Jan-02-24 09:00AM
Dec-12-23 05:05PM
Dec-06-23 09:40AM
Nov-29-23 06:42AM
Nov-15-23 09:15AM
Nov-14-23 09:00AM
Nov-13-23 11:03PM
Nov-03-23 11:43AM
Nov-02-23 10:21AM
Oct-31-23 09:40AM
09:40AM
08:50AM
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WARDELL LISA W Director Sep 13 '24 Option Exercise 32.03 67,976 2,177,271 173,061 Sep 13 05:39 PM WARDELL LISA W Director Sep 12 '24 Option Exercise 32.02 7,292 233,490 112,377 Sep 13 05:39 PM WARDELL LISA W Director Sep 13 '24 Sale 72.86 67,976 4,952,684 105,085 Sep 13 05:39 PM WARDELL LISA W Director Sep 12 '24 Sale 72.10 7,292 525,785 105,085 Sep 13 05:39 PM Herrera Maurice SVP - Chief Marketing Officer Sep 11 '24 Sale 70.54 8,165 575,987 14,750 Sep 13 04:34 PM LISA W. WARDELL Director Sep 13 '24 Proposed Sale 72.86 67,976 4,952,684 Sep 13 04:13 PM LISA W. WARDELL Director Sep 12 '24 Proposed Sale 72.10 7,292 525,785 Sep 12 04:15 PM MAURICE HERRERA Officer Sep 11 '24 Proposed Sale 70.54 8,165 575,987 Sep 11 04:18 PM WARDELL LISA W Director Sep 03 '24 Option Exercise 32.03 34,271 1,097,700 139,356 Sep 05 04:50 PM WARDELL LISA W Director Sep 04 '24 Option Exercise 32.03 19,936 638,550 125,021 Sep 05 04:50 PM WARDELL LISA W Director Sep 03 '24 Sale 73.78 34,271 2,528,497 105,085 Sep 05 04:50 PM WARDELL LISA W Director Sep 04 '24 Sale 73.82 19,936 1,471,687 105,085 Sep 05 04:50 PM LISA W. WARDELL Director Sep 04 '24 Proposed Sale 73.82 19,936 1,471,687 Sep 04 04:26 PM WARDELL LISA W Director Aug 29 '24 Option Exercise 43.39 30,115 1,306,690 135,200 Sep 03 04:42 PM WARDELL LISA W Director Aug 30 '24 Option Exercise 37.39 28,301 1,058,035 120,045 Sep 03 04:42 PM WARDELL LISA W Director Aug 29 '24 Sale 75.54 30,115 2,274,833 105,085 Sep 03 04:42 PM WARDELL LISA W Director Aug 30 '24 Sale 75.74 28,301 2,143,382 105,085 Sep 03 04:42 PM LISA W. WARDELL Director Sep 03 '24 Proposed Sale 73.78 34,271 2,528,497 Sep 03 04:32 PM LISA W. WARDELL Director Aug 30 '24 Proposed Sale 75.74 28,301 2,143,382 Aug 30 04:26 PM WARDELL LISA W Director Aug 28 '24 Option Exercise 43.39 36,156 1,568,809 141,241 Aug 29 04:33 PM WARDELL LISA W Director Aug 27 '24 Option Exercise 42.25 24,637 1,041,013 126,773 Aug 29 04:33 PM WARDELL LISA W Director Aug 28 '24 Sale 75.43 36,156 2,727,164 105,085 Aug 29 04:33 PM WARDELL LISA W Director Aug 27 '24 Sale 75.60 24,637 1,862,651 105,085 Aug 29 04:33 PM Gangadharan Manjunath VP, Chief Accounting Officer Aug 28 '24 Sale 75.40 944 71,178 4,720 Aug 29 04:31 PM LISA W. WARDELL Director Aug 29 '24 Proposed Sale 75.54 30,115 2,274,833 Aug 29 04:30 PM MANJUNATH GANGADHARAN Officer Aug 28 '24 Proposed Sale 75.55 944 71,319 Aug 28 04:19 PM LISA W. WARDELL Director Aug 28 '24 Proposed Sale 75.43 36,156 2,727,164 Aug 28 04:06 PM LISA W. WARDELL Director Aug 27 '24 Proposed Sale 75.60 24,637 1,862,651 Aug 27 04:46 PM WARDELL LISA W Director Aug 08 '24 Sale 71.51 67,330 4,815,085 94,804 Aug 09 04:12 PM Lisa W. Wardell Officer Aug 08 '24 Proposed Sale 74.71 67,330 5,030,224 Aug 08 05:01 PM Gangadharan Manjunath VP, Chief Accounting Officer May 22 '24 Sale 65.75 946 62,200 6,040 May 23 04:36 PM Herrera Maurice SVP - Chief Marketing Officer Dec 08 '23 Sale 60.00 4,200 252,000 24,519 Dec 11 04:26 PM Simpson Blake SVP, Chief Comms Officer Dec 06 '23 Sale 59.23 550 32,577 7,986 Dec 07 04:55 PM WARDELL LISA W Director Nov 13 '23 Option Exercise 33.90 62,757 2,127,462 224,891 Nov 15 04:14 PM WARDELL LISA W Director Nov 14 '23 Option Exercise 33.90 4,643 157,398 166,777 Nov 15 04:14 PM WARDELL LISA W Director Nov 13 '23 Sale 54.77 62,757 3,437,326 162,134 Nov 15 04:14 PM WARDELL LISA W Director Nov 14 '23 Sale 55.77 4,643 258,936 162,134 Nov 15 04:14 PM WARDELL LISA W Director Nov 09 '23 Option Exercise 33.90 78,570 2,663,523 242,338 Nov 13 04:26 PM WARDELL LISA W Director Nov 10 '23 Option Exercise 33.90 49,478 1,677,304 211,612 Nov 13 04:26 PM WARDELL LISA W Director Nov 08 '23 Option Exercise 33.90 45,623 1,546,620 206,861 Nov 13 04:26 PM WARDELL LISA W Director Nov 09 '23 Sale 55.57 78,570 4,366,103 163,768 Nov 13 04:26 PM WARDELL LISA W Director Nov 10 '23 Sale 55.19 49,478 2,730,483 162,134 Nov 13 04:26 PM WARDELL LISA W Director Nov 08 '23 Sale 55.15 45,623 2,516,268 161,238 Nov 13 04:26 PM WARDELL LISA W Director Nov 07 '23 Option Exercise 33.90 71,722 2,431,376 232,960 Nov 07 06:01 PM WARDELL LISA W Director Nov 06 '23 Option Exercise 33.90 20,233 685,899 181,471 Nov 07 06:01 PM WARDELL LISA W Director Nov 07 '23 Sale 55.30 71,722 3,966,384 161,238 Nov 07 06:01 PM WARDELL LISA W Director Nov 03 '23 Sale 55.02 29,172 1,605,006 161,238 Nov 07 06:01 PM WARDELL LISA W Director Nov 06 '23 Sale 55.01 20,233 1,113,003 161,238 Nov 07 06:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite